Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for fluticasone + umeclidinium + vilanterol

  1. Chronic obstructive pulmonary disease: fluticasone furoate, umeclidinium and vilanterol (Trelegy) (ES18)

    This evidence summary has been updated and replaced by NICE guideline 115.

    Evidence summary
    Published
    14 June 2018